CoRegen Inc.

👥 15 employees💰 Last funded Dec 2024
CoRegen is leveraging its groundbreaking master gene regulator platform to develop a broad range of therapeutics capable of controlling numerous genes throughout the body, with lead indications in solid tumors.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in CoRegen Inc.?
CoRegen Inc. has 1 investors on record on gritt.io.
When did CoRegen Inc. last raise funding?
The most recent investment in CoRegen Inc. recorded on gritt.io was in December 2024.
What industry is CoRegen Inc. in?
CoRegen Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.